Minerva Gastroenterology 2021 September;67(3)

EDITORIAL  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS CFree access

Minerva Gastroenterology 2021 September;67(3):215-7

Long-term benefits of viral clearance on extrahepatic manifestations of hepatitis C virus infection: the light at the end of the tunnel?

Giorgio M. SARACCO *

HTML PDF

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):218-26

Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome

Anna L. ZIGNEGO *, Silvia MARRI, Laura GRAGNANI

Abstract HTML PDF Materiale_Supplementare

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):227-33

Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin’s lymphoma in patients with chronic hepatitis C

Alessia CIANCIO *

Abstract HTML PDF

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):234-43

Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C

Liliana CHEMELLO *, Luisa CAVALLETTO, Sergio FERRARI, Salvatore MONACO

Abstract HTML PDF Materiale_Supplementare

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):244-53

Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C

Fabrizio FABRIZI *, Roberta CERUTTI, Carlo M. ALFIERI, Ezequiel RIDRUEJO

Abstract HTML PDF

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):254-63

Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C

Grazia PENNISI *, Federica SPATOLA, Lorenza DI MARCO, Vincenzo DI MARTINO, Vito DI MARCO

Abstract HTML PDF

REVIEW  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C

Minerva Gastroenterology 2021 September;67(3):264-72

The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C

Marco SACCO, Giorgio M. SARACCO *

Abstract HTML PDF

EDITORIAL  Free access

Minerva Gastroenterology 2021 September;67(3):273-5

Endoscopic retrograde cholangiopancreatography related perforations: is there plenty to discover?

Tawfik KHOURY, Amir MARI *, Wisam SBEIT

HTML PDF

ORIGINAL ARTICLE  

Minerva Gastroenterology 2021 September;67(3):276-82

Intestinal perforations after endoscopic retrograde cholangiopancreatography in the USA: a 16-year study using the National Inpatient Sample

Babatunde OLAIYA, Douglas G. ADLER *

Abstract HTML PDF Materiale_Supplementare

CASE REPORT  Free access

Minerva Gastroenterology 2021 September;67(3):283-8

Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient

Gianni TESTINO *, Rinaldo PELLICANO

Abstract HTML PDF

REVIEW  

Minerva Gastroenterology 2021 September;67(3):289-98

The efficacy of fasting regimens on health outcomes: a systematic overview

Andrea A. SARRO *, Anil B. PAYEDIMARRI, Diego D. CONCINA, Marco F. FARSONI, Nicola N. PIU, Carmela RINALDI, Massimiliano P. PANELLA

Abstract HTML PDF Materiale_Supplementare

LETTERS TO THE EDITOR  

Minerva Gastroenterology 2021 September;67(3):299-300

Liver stiffness: a motivational tool for achieving alcohol abstention in alcohol use disorder patients?

Gianni TESTINO *, Rinaldo PELLICANO

HTML PDF